The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37. // Current Opinion in Virology. – URL: https://www.sciencedirect.com/science/article/pii/S187962572600060X?dgcid=rss_sd_all
The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37. Current Opinion in Virology. https://www.sciencedirect.com/science/article/pii/S187962572600060X?dgcid=rss_sd_all
“The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37.” Current Opinion in Virology.
@article{article7252,
title = {The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37},
journal = {Current Opinion in Virology},
url = {https://www.sciencedirect.com/science/article/pii/S187962572600060X?dgcid=rss_sd_all}
}